Lexicon Pharmaceuticals reported $136.18M in Assets for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Assets Change
Abbott ABT:US $ 74007M 1189M
Acadia Pharmaceuticals ACAD:US $ 624.25M 75.87M
Acorda Therapeutics ACOR:US $ 424.14M 31.33M
Agios Pharmaceuticals AGIO:US $ 1335.86M 101.88M
Akebia Therapeutics AKBA:US $ 535.36M 9.81M
Alnylam Pharmaceuticals ALNY:US $ 3433.54M 209.76M
AstraZeneca AZN:LN 100273M 5090M
Biomarin Pharmaceutical BMRN:US $ 6062.71M 59.38M
Clovis Oncology CLVS:US $ 451.53M 21.3M
Coherus Biosciences CHRS:US $ 593.39M 85.95M
Esperion Therapeutics ESPR:US $ 342.85M 38.74M
Halozyme Therapeutics HALO:US $ 1162.25M 57.82M
Illumina ILMN:US $ 15274M 57M
Insmed INSM:US $ 1.15B 90.19M
Lexicon Pharmaceuticals LXRX:US $ 136.18M 731K
Merk MRK:US $ 106668M 974M
Novartis NOVN:VX SF 125218M 6577M
Regulus Therapeutics RGLS:US $ 60.98M 7.47M